 Cardiomyopathy, Hypertrophic, Familial
"Cardiomyopathy, Hypertrophic, Familial" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An autosomal dominant inherited form of HYPERTROPHIC CARDIOMYOPATHY. It results from any of more than 50 mutations involving genes encoding contractile proteins such as VENTRICULAR MYOSINS; cardiac TROPONIN T; ALPHA-TROPOMYOSIN.
| Descriptor ID |
D024741
|
| MeSH Number(s) |
C14.280.238.100.500 C14.280.484.150.070.160.500 C16.320.160
|
| Concept/Terms |
Cardiomyopathy, Hypertrophic, Familial- Cardiomyopathy, Hypertrophic, Familial
- Cardiomyopathy, Familial Hypertrophic
- Cardiomyopathies, Familial Hypertrophic
- Familial Hypertrophic Cardiomyopathies
- Hypertrophic Cardiomyopathies, Familial
- Hypertrophic Cardiomyopathy, Familial
- Familial Hypertrophic Cardiomyopathy
- Ventricular Hypertrophy, Familial
- Familial Ventricular Hypertrophies
- Familial Ventricular Hypertrophy
- Hypertrophy, Familial Ventricular
- Ventricular Hypertrophies, Familial
- Ventricular Hypertrophy, Hereditary
- Asymmetric Septal Hypertrophy, Familial
- Hereditary Ventricular Hypertrophy
- Hereditary Ventricular Hypertrophies
- Hypertrophies, Hereditary Ventricular
- Hypertrophy, Hereditary Ventricular
- Ventricular Hypertrophies, Hereditary
|
Below are MeSH descriptors whose meaning is more general than "Cardiomyopathy, Hypertrophic, Familial".
- Diseases [C]
- Cardiovascular Diseases [C14]
- Heart Diseases [C14.280]
- Cardiomyopathies [C14.280.238]
- Cardiomyopathy, Hypertrophic [C14.280.238.100]
- Cardiomyopathy, Hypertrophic, Familial [C14.280.238.100.500]
- Heart Valve Diseases [C14.280.484]
- Aortic Valve Stenosis [C14.280.484.150]
- Aortic Stenosis, Subvalvular [C14.280.484.150.070]
- Cardiomyopathy, Hypertrophic [C14.280.484.150.070.160]
- Cardiomyopathy, Hypertrophic, Familial [C14.280.484.150.070.160.500]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
- Cardiomyopathy, Hypertrophic, Familial [C16.320.160]
Below are MeSH descriptors whose meaning is more specific than "Cardiomyopathy, Hypertrophic, Familial".
This graph shows the total number of publications written about "Cardiomyopathy, Hypertrophic, Familial" by people in this website by year, and whether "Cardiomyopathy, Hypertrophic, Familial" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 | | 2003 | 3 | 0 | 3 | | 2004 | 2 | 0 | 2 | | 2007 | 1 | 0 | 1 | | 2009 | 2 | 0 | 2 | | 2010 | 1 | 0 | 1 | | 2014 | 1 | 0 | 1 | | 2016 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Cardiomyopathy, Hypertrophic, Familial" by people in Profiles.
-
Birch CL, Behunin SM, Lopez-Pier MA, Danilo C, Lipovka Y, Saripalli C, Granzier H, Konhilas JP. Sex dimorphisms of crossbridge cycling kinetics in transgenic hypertrophic cardiomyopathy mice. Am J Physiol Heart Circ Physiol. 2016 07 01; 311(1):H125-36.
-
Baxi AJ, Restrepo CS, Vargas D, Marmol-Velez A, Ocazionez D, Murillo H. Hypertrophic Cardiomyopathy from A to Z: Genetics, Pathophysiology, Imaging, and Management. Radiographics. 2016 Mar-Apr; 36(2):335-54.
-
Green EM, Wakimoto H, Anderson RL, Evanchik MJ, Gorham JM, Harrison BC, Henze M, Kawas R, Oslob JD, Rodriguez HM, Song Y, Wan W, Leinwand LA, Spudich JA, McDowell RS, Seidman JG, Seidman CE. A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice. Science. 2016 Feb 05; 351(6273):617-21.
-
Magida JA, Leinwand LA. Metabolic crosstalk between the heart and liver impacts familial hypertrophic cardiomyopathy. EMBO Mol Med. 2014 04; 6(4):482-95.
-
Bolling MC, Veenstra MJ, Jonkman MF, Diercks GF, Curry CJ, Fisher J, Pas HH, Bruckner AL. Lethal acantholytic epidermolysis bullosa due to a novel homozygous deletion in DSP: expanding the phenotype and implications for desmoplakin function in skin and heart. Br J Dermatol. 2010 Jun; 162(6):1388-94.
-
Sivaramakrishnan S, Ashley E, Leinwand L, Spudich JA. Insights into human beta-cardiac myosin function from single molecule and single cell studies. J Cardiovasc Transl Res. 2009 Dec; 2(4):426-40.
-
Luckey SW, Walker LA, Smyth T, Mansoori J, Messmer-Kratzsch A, Rosenzweig A, Olson EN, Leinwand LA. The role of Akt/GSK-3beta signaling in familial hypertrophic cardiomyopathy. J Mol Cell Cardiol. 2009 May; 46(5):739-47.
-
Kaufman BD, Auerbach S, Reddy S, Manlhiot C, Deng L, Prakash A, Printz BF, Gruber D, Papavassiliou DP, Hsu DT, Sehnert AJ, Chung WK, Mital S. RAAS gene polymorphisms influence progression of pediatric hypertrophic cardiomyopathy. Hum Genet. 2007 Dec; 122(5):515-23.
-
Maass AH, Ikeda K, Oberdorf-Maass S, Maier SK, Leinwand LA. Hypertrophy, fibrosis, and sudden cardiac death in response to pathological stimuli in mice with mutations in cardiac troponin T. Circulation. 2004 Oct 12; 110(15):2102-9.
-
Taylor MR, Carniel E, Mestroni L. Familial hypertrophic cardiomyopathy: clinical features, molecular genetics and molecular genetic testing. Expert Rev Mol Diagn. 2004 Jan; 4(1):99-113.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|